PNC Financial Services Group
EBS icon

PNC Financial Services Group’s Emergent Biosolutions EBS Stock Holding History

PNC Financial Services Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.33K Buy
281
+35
+14% +$363 ﹤0.01% 4533
2025
Q4 		$3.04K Buy
246
+10
+4% +$107 ﹤0.01% 4418
2025
Q3 		$2.08K Sell
236
-438
-65% -$3.41K ﹤0.01% 4491
2025
Q2 		$4.3K Buy
+674
New +$3.86K ﹤0.01% 4191
2025
Q1 		– Sell
-34
Closed -$325 – 4933
2024
Q4 		$325 Hold
34
– – ﹤0.01% 4590
2024
Q3 		$284 Hold
34
– – ﹤0.01% 4635
2024
Q2 		$232 Buy
34
+29
+580% +$125 ﹤0.01% 4644
2024
Q1 		$13 Sell
5
-226
-98% -$509 ﹤0.01% 4678
2023
Q4 		$554 Buy
231
+202
+697% +$475 ﹤0.01% 4396
2023
Q3 		$99 Sell
29
-6,612
-100% -$36.7K ﹤0.01% 4566
2023
Q2 		$48.8K Buy
6,641
+2,687
+68% +$24.9K ﹤0.01% 3078
2023
Q1 		$41K Buy
3,954
+3,581
+960% +$43.3K ﹤0.01% 3098
2022
Q4 		$4.41K Sell
373
-1,588
-81% -$24.6K ﹤0.01% 4029
2022
Q3 		$41K Sell
1,961
-1,209
-38% -$33.6K ﹤0.01% 3077
2022
Q2 		$99K Sell
3,170
-1,311
-29% -$44.8K ﹤0.01% 2579
2022
Q1 		$184K Sell
4,481
-776
-15% -$34.2K ﹤0.01% 2318
2021
Q4 		$228K Buy
5,257
+623
+13% +$28.2K ﹤0.01% 2171
2021
Q3 		$232K Buy
4,634
+200
+5% +$12.1K ﹤0.01% 2101
2021
Q2 		$280K Sell
4,434
-133
-3% -$8.54K ﹤0.01% 2005
2021
Q1 		$423K Sell
4,567
-332
-7% -$34K ﹤0.01% 1681
2020
Q4 		$438K Buy
4,899
+721
+17% +$66.2K ﹤0.01% 1564
2020
Q3 		$431K Sell
4,178
-2,211
-35% -$238K ﹤0.01% 1430
2020
Q2 		$506K Buy
6,389
+1,686
+36% +$126K ﹤0.01% 1386
2020
Q1 		$272K Buy
4,703
+812
+21% +$46.8K ﹤0.01% 1645
2019
Q4 		$211K Buy
3,891
+670
+21% +$36.3K ﹤0.01% 2032
2019
Q3 		$169K Buy
3,221
+33
+1% +$1.54K ﹤0.01% 2230
2019
Q2 		$154K Sell
3,188
-31,461
-91% -$1.51M ﹤0.01% 2312
2019
Q1 		$1.75M Buy
34,649
+7,511
+28% +$443K ﹤0.01% 1080
2018
Q4 		$1.61M Sell
27,138
-6,802
-20% -$438K ﹤0.01% 1072
2018
Q3 		$2.23M Sell
33,940
-251
-0.7% -$14.6K ﹤0.01% 1041
2018
Q2 		$1.73M Buy
34,191
+31,344
+1,101% +$1.63M ﹤0.01% 1114
2018
Q1 		$149K Buy
2,847
+1,482
+109% +$73.9K ﹤0.01% 2338
2017
Q4 		$62K Buy
1,365
+436
+47% +$18.4K ﹤0.01% 2815
2017
Q3 		$37K Buy
929
+59
+7% +$2.13K ﹤0.01% 3092
2017
Q2 		$29K Buy
870
+101
+13% +$3.12K ﹤0.01% 3169
2017
Q1 		$23K Sell
769
-9,516
-93% -$290K ﹤0.01% 3235
2016
Q4 		$338K Sell
10,285
-58
-0.6% -$1.74K ﹤0.01% 1815
2016
Q3 		$325K Sell
10,343
-42,839
-81% -$1.24M ﹤0.01% 1805
2016
Q2 		$1.49M Buy
53,182
+40,714
+327% +$1.6M ﹤0.01% 1072
2016
Q1 		$453K Buy
12,468
+4,396
+54% +$155K ﹤0.01% 1608
2015
Q4 		$322K Sell
8,072
-8,869
-52% -$309K ﹤0.01% 1778
2015
Q3 		$483K Sell
16,941
-983
-5% -$32.4K ﹤0.01% 1582
2015
Q2 		$590K Sell
17,924
-9,587
-35% -$297K ﹤0.01% 1539
2015
Q1 		$790K Sell
27,511
-3,470
-11% -$99.5K ﹤0.01% 1363
2014
Q4 		$843K Buy
30,981
+4,831
+18% +$115K ﹤0.01% 1268
2014
Q3 		$558K Buy
26,150
+21,730
+492% +$498K ﹤0.01% 1417
2014
Q2 		$99K Buy
4,420
+3,720
+531% +$86.6K ﹤0.01% 2284
2014
Q1 		$19K Buy
700
+100
+17% +$2.53K ﹤0.01% 2864
2013
Q4 		$14K Buy
+600
New +$12.5K ﹤0.01% 2900

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PNC Financial Services Group's EBS Position: Q1 2026 in Review

PNC Financial Services Group increased its Emergent Biosolutions (EBS) stake by 14% in Q1 2026, buying an estimated $363 and bringing the position to 281 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #4533.

PNC Financial Services Group first reported a position in EBS in Q4 2013 and has held it in 49 quarters since. The position peaked at $2.23M in Q3 2018. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • PNC Financial Services Group held 281 shares of Emergent Biosolutions worth $2.33K as of Q1 2026.
  • PNC Financial Services Group bought 35 Emergent Biosolutions shares in Q1 2026, an estimated $363.
  • Emergent Biosolutions made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4533 holding.
  • PNC Financial Services Group first reported a position in Emergent Biosolutions in Q4 2013 and has held it in 49 quarters since.
  • PNC Financial Services Group's Emergent Biosolutions position peaked at $2.23M in Q3 2018.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.